1. CoMSIA 3D-QSAR Analysis of 3,4-Dihydroquinazoline Derivatives Against Human Colon Cancer HT-29 Cells.
- Author
-
Gi Hyun Kwon, Sehyeon Cho, Jinsung Lee, Joo Mi Sohn, Joon Seok Byun, Kyung-Tae Lee, and Jae Yeol Lee
- Subjects
COMPARATIVE molecular field analysis ,QSAR models ,ANTINEOPLASTIC agents ,HYDROGEN bonding ,COLON cancer treatment - Abstract
A series of 3,4-dihydroquinazoline derivatives with anti-cancer activities against human colon cancer HT-29 cell were subjected to three-dimensional quantitative structure-activity relationship (3D-QSAR) studies using the comparative molecular similarity indices analysis (CoMSIA) approaches. The most potent compound, BK10001 was used to align the molecules. As a result, the best prediction was obtained with CoMSIA combined electrostatic, hydrophobic, and hydrogen-bond acceptor fields (q² = 0.648, r² = 0.882). This model was validated by an external test set of six compounds giving satisfactory predictive r² values of 0.879. This model would guide the design of potent 3,4-dihydroquinazoline derivatives as anti-cancer agent for the treatment of human colon cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF